...
首页> 外文期刊>Acta medica Okayama >Assessment of Melanoma-Initiating Cell Markers and Conventional Parameters in Sentinel Lymph Nodes of Malignant Melanoma
【24h】

Assessment of Melanoma-Initiating Cell Markers and Conventional Parameters in Sentinel Lymph Nodes of Malignant Melanoma

机译:恶性黑色素瘤前哨淋巴结中黑色素瘤起始细胞标记物和常规参数的评估。

获取原文

摘要

Sentinel lymph node (SLN) biopsies have widely been used for the detection of occult LN metastasis of malignant melanoma (MM). In addition to conventional biomarkers, we assessed the diagnostic and prognostic significance of melanoma-initiating cell (MIC) markers in SLNs of MM. We examined the expressions of gp100, MART-1 and tyrosinase mRNA for routine diagnosis and those of ABCB5, CD133, nestin, KDM5B, NGFR and RANK mRNA as MIC markers. The presence of micrometastasis was confirmed immunohistochemically using antibodies to S-100, HMB-45, MART-1, and tyrosinase. Discordance between immunohistochemical and molecular data was observed in 14 of 70 (20.0%) patients, among whom five (7.1%) were positive for only molecular markers;two of these five patients tested positive for micrometastasis by repeated immunohistochemical stainings. The quantitative expression levels of gp100, MART-1, and tyrosinase mRNA were significantly higher in the metastatic LNs;the cut-off values remain to be elucidated. ABCB5 mRNA expression was detected more frequently in the metastatic SLNs (p<0.05) and in the group of patients with recurrence. To make a definite diagnosis of metastasis, we still need a combination of immunohistochemical and molecular probes. ABCB5 might be a suitable molecular marker for the detection of melanoma-initiating cells in SLNs.
机译:前哨淋巴结(SLN)活检已广泛用于检测恶性黑色素瘤(MM)的隐匿性LN转移。除了常规的生物标志物,我们评估了MM SLNs中黑色素瘤起始细胞(MIC)标志物的诊断和预后意义。我们检查了用于常规诊断的gp100,MART-1和酪氨酸酶mRNA的表达以及作为MIC标记的ABCB5,CD133,nestin,KDM5B,NGFR和RANK mRNA的表达。使用针对S-100,HMB-45,MART-1和酪氨酸酶的抗体通过免疫组织化学方法确认了微转移的存在。 70例患者中有14例(20.0%)观察到免疫组化与分子数据之间的不一致,其中5例(7.1%)仅对分子标记呈阳性;这5例患者中有2例通过反复免疫组化染色检测为微转移阳性。在转移性LNs中,gp100,MART-1和酪氨酸酶mRNA的定量表达水平显着升高;其临界值仍有待阐明。在转移性SLNs和复发患者组中更频繁地检测到ABCB5 mRNA表达(p <0.05)。为了确定转移的诊断,我们仍然需要免疫组织化学和分子探针的组合。 ABCB5可能是检测SLN中黑色素瘤起始细胞的合适分子标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号